Sign in Join
  • Home
    • About Us
      • Privacy Policy
        • Disclaimer
    • Advertise On Market Exclusive
    • Sitemap
    • Submit a Scoop!
    • Contact Us
  • Stock Market News
  • Stocks
    • Analyst Ratings
    • Insider Trading
    • SEC Filings
    • Earnings
  • Cannabis Stocks News
  • Biotech Stocks
  • Small Caps
  • Blockchain & Cryptocurrency
  • Become a Contributor!
Sign in
Welcome!Log into your account
Forgot your password?
Sign up
Welcome!Register for an account
A password will be e-mailed to you.
Password recovery
Recover your password
Search
  • Sign in / Join
  • My Account
  • orders
Sign in
Welcome! Log into your account
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • Home
    • About Us
      • Privacy Policy
        • Disclaimer
    • Advertise On Market Exclusive
    • Sitemap
    • Submit a Scoop!
    • Contact Us
  • Stock Market News
  • Stocks
    • Analyst Ratings
    • Insider Trading
    • SEC Filings
    • Earnings
  • Cannabis Stocks News
  • Biotech Stocks
  • Small Caps
  • Blockchain & Cryptocurrency
  • Become a Contributor!
Home SEC Filings Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Unregistered Sales of Equity Securities
  • SEC Filings

Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Unregistered Sales of Equity Securities

By
ME Staff 8-k
-
January 15, 2020
Share on Facebook
Tweet on Twitter

Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Unregistered Sales of Equity Securities
Item 3.02

On January 13, 2020 Foris Ventures, LLC (“Foris”), an entity affiliated with director John Doerr and which beneficially owns greater than five percent of the Company’s outstanding common stock, delivered to the Company an irrevocable notice of cash exercise with respect to a warrant (the “Warrant”) to purchase 4,877,386 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) issued by the Company on August 17, 2018 (the “Warrant Exercise”). On January 14, 2020, the Company received approximately $14.0 million from Foris in connection with the Warrant Exercise representing 4,877,386 shares of Common Stock at an exercise price of $2.87 per share. The issuance of the Warrant and related matters were reported in Current Reports on Form 8-K filed by the Company with the Securities and Exchange Commission (the “SEC”) on August 20, 2018 and on July 15, 2019, which are incorporated herein by reference.
The shares of Common Stock to be issued in connection with the Warrant Exercise will be issued in a private placement to the exemption from registration under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated under the Securities Act (“Regulation D”), without general solicitation, made only to and with “accredited investors” as defined in Regulation D.
About Amyris, Inc. (NASDAQ:AMRS)

Story continues below

Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.

An ad to help with our costs
  • TAGS
  • 8-K
  • AMRS
  • Amyris Inc
  • NASDAQ:AMRS
  • SEC Filings
SHARE
Facebook
Twitter
ME Staff 8-k

RELATED ARTICLESMORE FROM AUTHOR

Centrus Energy Corp. (NYSEMKT:LEU) Files An 8-K Entry into a Material Definitive Agreement

VEMANTI GROUP, INC. (OTCMKTS:VMNT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain...

ICONIX BRAND GROUP, INC. (NASDAQ:ICON) Files An 8-K Other Events

Compass, Inc. (TSE:CMZ.UN) Files An 8-K Material Modification to Rights of Security Holders

Hudson Technologies, Inc. (NASDAQ:HDSN) Files An 8-K Other Events

3D PIONEER SYSTEMS, INC. (OTCMKTS:DPSM) Files An 8-K Entry into a Material Definitive Agreement

A word from the sponsor
Latest Articles
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Recent Posts

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Sponsored
/* */

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 25, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 18, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 11, 2023

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019
// AST – IMS - [MarketExclusive_ROS]
Go to mobile version